We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Allergan

News List

Got Lolo? Allergan hypes ultralow-estrogen birth control in first major brand push fiercepharma
August 01, 2018
In its latest women’s health advertising, Allergan sticks with its straight-talk, empowerment-oriented messaging—but this time, it attaches a brand name. The ultralow-dose birth control pill Lo Loestrin Fe stars in the new push, “Women Who Know,” now runn
Amgen, Allergan Receive Positive CHMP for ABP 215 americanpharmaceuticacreview
November 13, 2017
Amgen and Allergan are collaborating on the development and commercialization of four oncology biosimilars. Amgen has a total of 10 biosimilars in its portfolio, one of which has been approved by the EC.
SNL veteran Vanessa Bayer joins Allergan for birth control Q&A on streets of NYC fiercepharma
August 31, 2017
“Why is ‘the pill’ called ‘the pill?’” comedic actress Vanessa Bayer asks in one of the birth control awareness videos in Allergan's newest digital campaign.